Genetics of Psychosis Alzheimer Disease

Dear Colleagues,

Alzheimer’s disease is a neurodegenerative disorder characterized by a progressive deterioration of memory and cognitive functions, often associated with neuropsychiatric symptoms (depression; psychosis), that further compromise patients' behavior. There are many genetic factors that affect this disease. Even though we believe we know enough about the pathogenesis of Alzheimer's disease, there is no effective drug treatment to treat degenerative diseases and improve dementia symptoms.

For our Special Issue in the journal Applied Sciences, titled “Genetics of Psychosis in Alzheimer’s Disease,” we would like to invite all investigators who are interested in this topic to contribute, and especially we encourage multi-disciplinary collaboration that share more ideas about the future development of its pathology, diagnosis, and treatment. Any original research article or review is welcome.

Dr. Paolo Olgiati
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Alzheimer’s disease
• pharmacogenetics
• gene genetics
• neuroscience